Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

Earlier this year, NMD4C, MDC and Quebec SMA Network hosted the first interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal Muscular Atrophy (SMA).

To complement this training session, the NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures.

This workshop will be taking place the day before the Allied Professionals Forum in Montreal.

Please ensure you register before the deadline of June 18th, 2024.

Please ensure that you meet the eligibility criteria:

  • Must be a physiotherapist or occupational therapist at a Canadian institution/clinic evaluating patients of any age with SMA.
  • Must be a NMD4C member.

Disclaimer:

We have a limited number of seats available for this workshop (in-person only). Participants will be selected based on considerations related to geography, case load and clinic needs. There is a discounted hotel room rate as part of the Allied Professionals Forum meeting and financial support for travel and accommodations will be provided (details to follow upon acceptance).

Register Here!

Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

Read next...

CPNG LOGO

Zolgensma® Safety Update and CPNG Guidance for Families

The Canadian Pediatric Neuromuscular Group (CPNG) has issued a statement for families regarding recent reports of tumours in children treated with Zolgensma® (onasemnogene abeparvovec) gene therapy for spinal muscular atrophy (SMA). The statement outlines current evidence, considerations for follow-up care, and information for families and healthcare providers.

2026 Trainee Publication of the Year Awardee Spotlight on Jules Granet

Could You Be Our Next Awardee? Meet Jules Granet, NMD4C’s 2026 Publication of the Year Awardee

Nominations are open till by 18 January 2027!
In 2026, Jules Granet, a PhD Candidate at McGill University and trainee in Dr. Natasha Chang’s laboratory received an NMD4C Publication of the Year Award for research investigating how muscle stem cell dysfunction contributes to impaired muscle regeneration in Duchenne muscular dystrophy. Nominate yourself or a neuromuscular colleague whose research, clinical care, leadership, advocacy, or community contributions deserve to be recognized.

Save the date: 8th Ottawa International Conference On Neuromuscular Disease & Biology

Early Bird Registration Now Open: 8th Ottawa International Conference On Neuromuscular Disease & Biology

We are happy to announce that early bird registration is now open for the 8th Ottawa International Conference On Neuromuscular Disease & Biology which will be held on October 14-16, 2027 at the Fairmont Château Laurier in Ottawa, Canada. Now under the leadership of NMD4C Investigators; Dr. Mireille Khacho, Dr. Hanns Lochmuller, Dr. Bernard Jasmin, and Dr. Rashmi Kothary.